Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Colonic Neoplasms × Panitumumab × Clear all

Phase

Phase 2 14 Phase 1/2 4 Phase 3 3 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Oxaliplatin 6 Fluorouracil 6 Leucovorin 5 Bevacizumab 4 XELOX 2 Watchful Waiting 2 Irinotecan 2 Cetuximab 2 Capecitabine 2 sulindac sulfone 1 encorafenib 1 dehydroftorafur 1 Tranexamic Acid 1 Standard of Care 1 Radiofrequency Ablation 1 Preoperative Exercise 1 Positron Emission Tomography Computed Tomography 1 Panitumumab 1 Observation 1 Neoadjuvant Therapy 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Iohexol 1 Indocyanine Green 1 In Situ Hybridization, Fluorescence 1 Immunohistochemistry 1 Gene Expression Profiling 1 Fibroblast Growth Factor 7 1 Exercise 1 Cytogenetic Analysis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00647530 2019-05-17

FOxTROT

University of Birmingham

Phase 2/3 Unknown

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡